COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Income Statement
NASDAQ:COLL - Nasdaq - US19459J1043 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 664.28M | 631.45M | 566.77M | 463.90M | 276.90M | |||
| Cost Of Goods | 281.07M | 254.10M | 240.60M | 249.70M | 126.30M | |||
| Gross Profit | 383.21M | 377.34M | 326.17M | 214.30M | 150.60M | |||
| Operating Expenses | 241.10M | 207.45M | 150.71M | 144.80M | 125.40M | |||
| Research and Development | N/A | 0.00 | 0.00 | 4.00M | 9.50M | |||
| Selling, General, and Administrative Expenses | 244.80M | 210.36M | 150.71M | 140.90M | 116.00M | |||
| Operating Income | 142.11M | 169.90M | 175.46M | 69.40M | 25.10M | |||
| Interest Income/Expense | -65.71M | -60.00M | -67.72M | -62.20M | -21.00M | |||
| Non Recurring Items | N/A | -11.33M | -32.00M | -36.10M | -7.50M | |||
| Income Before Taxes | 65.07M | 98.57M | 75.73M | -28.80M | -3.40M | |||
| Income Tax | 21.17M | 29.38M | 27.58M | -3.80M | -74.90M | |||
| Net Income | 43.89M | 69.19M | 48.16M | -25.00M | 71.50M | |||
| EBITDA | 332.40M | 339.06M | 324.72M | 203.60M | 94.00M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.08 | 1.71 | 1.15 | -0.74 | 1.74 | |||
| Non GAAP EPS | 6.49 | 6.45 | 1.18 | 0.56 | 0.39 | |||
| Statistics | ||||||||
| Gross Profit Margin | 57.69% | 59.76% | 57.55% | 46.20% | 54.39% | |||
| Profit Margin | 6.61% | 10.96% | 8.50% | -5.39% | 25.82% | |||
| Operating Profit Margin | 21.39% | 26.91% | 30.96% | 14.96% | 9.06% | |||
All data in USD